# Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer

> **NCT06064019** · NA · RECRUITING · sponsor: **SciBase AB** · enrollment: 150 (estimated)

## Conditions studied

- Keratinocyte Skin Cancer

## Interventions

- **DEVICE:** Nevisense

## Key facts

- **NCT ID:** NCT06064019
- **Lead sponsor:** SciBase AB
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-13
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06064019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06064019, "Evaluation of Nevisense as Support Tool for the Diagnose of Keratinocyte Skin Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06064019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*